Related Experiment Video

Updated: May 27, 2026

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
05:57

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension

Published on: May 17, 2024

Clinical inquiries. Which combination drug therapies are most effective for hypertension?

Paul Crawford1, David Dy, Misty Carney

  • 1Nellis Family Medicine Residency, Las Vegas, NV, USA.

The Journal of Family Practice
|November 4, 2011
PubMed

Insights

Combining hypertension medications at lower doses generally reduces cardiovascular risks more than single drugs. Specific combinations like benazepril and amlodipine show better outcomes than benazepril with hydrochlorothiazide.

Area of Science:

  • Cardiology
  • Pharmacology
  • Public Health

Background:

  • Hypertension management is crucial for reducing cardiovascular morbidity and mortality.
  • Optimal medication strategies, particularly combination therapies, require further elucidation.
  • Evidence-based guidelines are essential for effective hypertension treatment.

Purpose of the Study:

  • To evaluate the comparative effectiveness of different hypertension medication combinations on cardiovascular outcomes.
  • To assess the safety and adverse effect profiles of various antihypertensive drug combinations.
  • To provide evidence-based recommendations for optimizing hypertension treatment strategies.

Main Methods:

  • Analysis of large meta-analyses and randomized controlled trials (RCTs).
  • Comparison of cardiovascular event rates (stroke, coronary heart disease) and mortality.
  • Assessment of adverse effect profiles associated with combination therapies versus monotherapy.

Main Results:

  • Combination therapies at lower doses generally outperform monotherapy in reducing cardiovascular outcomes.
  • Benazepril plus amlodipine demonstrated superior efficacy over benazepril plus hydrochlorothiazide for composite endpoints.
  • Combining angiotensin-converting enzyme inhibitors (ACE-I) with angiotensin receptor blockers (ARBs) significantly increases renal complication and mortality risks.

Conclusions:

  • Combination antihypertensive therapy, particularly at lower doses, is generally more effective than monotherapy for cardiovascular risk reduction.
  • Certain combinations, such as benazepril and amlodipine, offer improved cardiovascular event reduction.
  • Concurrent use of ACE-I and ARBs should be avoided due to increased risks of renal complications and mortality.

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...